Using the transtheoretical model to stage screening behavior for colorectal cancer

Health Education and Behavior

Volumn 30, Issue 3, 2003, Pages 322-336

  Trauth, Jeanette M ^a   Ling, Bruce S ^b   Weissfeld, Joel L ^c   Schoen, Robert E ^a   Hayran, Mutlu ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cancer screening behavior; Colorectal cancer; Stages of change; Transtheoretical model

Indexed keywords

AGE; BLOOD ANALYSIS; CANCER SCREENING; CANCER STAGING; COLORECTAL CARCINOMA; GENDER; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; MEDICAL EXAMINATION; OCCULT BLOOD; PRESCRIPTION; REVIEW; SIGMOIDOSCOPY; TELEPHONE; UNITED STATES;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; PHYSICIAN-PATIENT RELATIONS; POVERTY AREAS; REGRESSION ANALYSIS;

EID: 2342427205     PISSN: 10901981     EISSN: None     Source Type: Journal    
DOI: 10.1177/1090198103030003007     Document Type: Review

References (38)

1. American Cancer Society: Cancer Facts and Figures, 1999. Atlanta, GA, American Cancer Society, 1999. (Pub. No. 5008.99.)
2. Schrag D, Weeks J: Costs and cost-effectiveness of colorectal cancer prevention and therapy. Semin Oncol 26:561-568, 1999.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study (published erratum appears in N Engl J Med 329:672, 1993). N Engl J Med 328:1365-1371, 1993.
4. Mandel JS, Church TR, Ederer F, Bond JH: Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Nat Cancer Inst 91:434-437, 1999.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondegaard O: Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 348:1467-1471, 1996.
6. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al: Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 348:1472-1477, 1996.
7. Selby JV, Friedman GD, Quesenberry CP, Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653-657, 1992.
8. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM: Screening sigmoidoscopy and colorectal cancer mortality. J Nat Cancer Inst 84:1572-1575, 1992.
9. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG: Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Nat Cancer Inst 85:1311-1318, 1993.
10. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329(27):1977-1981, 1993.
11. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al: Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112:594-642, 1997.
12. Report of the U.S. Preventive Services Task Force: Guide to Clinical Preventive Services. Baltimore, MD, Williams and Wilkins, 1996.
13. Department of Health and Human Services. Office of Disease Prevention and Health Promotion: Healthy People 2010 (2nd ed.). Washington, DC, Government Printing Office, 2000.
14. Brown ML, Potosky AL, Thompson GB, Kessler LG: The knowledge and use of screening tests for colorectal and prostate cancer: Data from the 1987 National Health Interview Survey. Prev Med 19:562-574, 1990.
15. Centers for Disease Control and Prevention: Screening for colorectal cancer - United States, 1997. MMWR 48:116-121, 1999.
16. Gallup Organization: Adults' Knowledge and Experience With Testing for Colorectal Cancer - A Study of Adults Age 50 and Over. Atlanta, GA, American Cancer Society, 1998.
17. Centers for Disease Control and Prevention: Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR 50:162-166, 2001.
18. Glanz K, Lewis FM, Rimer BK: Health Behavior and Health Education: Theory, Research, and Practice (2nd ed.). San Francisco, Jossey-Bass, 1997.
19. Rakowski W, Dube CE, Marcus BH, Prochaska JO, Velicer WF, Abrams DB: Assessing elements of women's decisions about mammography. Health Psychol 11(2):111-118, 1992.
20. Rakowski W, Fulton JP, Feldman JP: Women's decision making about mammography: A replication of the relationship between stages of adoption and decisional balance. Health Psychol 12(3):209-214, 1993.
21. Pearlman DN, Rakowski W, Ehrich B: The information environment of women and mammography screening: Assessing reciprocity in social relationships. J Womens Health 4 (5):541-553, 1995.
22. Rakowski W, Dube CE, Goldstein MG: Considerations for extending the transtheoretical model of behavior change to screening mammography. Health Educ Res Theory Practice 11(1) 77-96, 1996.
23. Rakowski W, Ehrich B, Dube CE, Pearlman DN, Goldstein MG, Peterson KK, Rimer BK, Woolverton H: Screening mammography and constructs from the transtheoretical model: Associations using two definitions of the stages-of-adoption. Ann Behav Med 18(2):91-100, 1996.
24. Rakowski W: The transtheoretical model of behavior change: Application to clinical practice. Mind/Body Med 1(4):207-223, 1996.
25. Pearlman DN, Rakowski W, Clark MA, Ehrich B, Rimer BK, Goldstein MG, Woolverton H, Dube CE: Why do women's attitudes toward mammography change over time? Implications for physician-patient communication. Cancer Epidemiol Biomarkers Prev 6:451-457, 1997.
26. Rakowski W, Clark MA, Pearlman DN, Ehrich B, Rimer BK, Goldstein MG, Dube CE, Woolverton H: Integrating pros & cons for mammography and Pap testing: Extending the construct of decisional balance to two behaviors. Prev Med 26:664-673, 1997.
27. Sugg Skinner C, Arfken CL, Sykes RK: Knowledge, perceptions, and mammography stage of adoption among older urban women. Am J Prev Med 14(1):54-63, 1998.
28. Rakowski W, Ehrich B, Goldstein MG, Rimer BK, Pearlman DN, Clark MA, Velicer WF, Woolverton H: Increasing mammography among women aged 40-74 by use of a stage-matched, tailored intervention. Prev Med 27:748-756, 1998.
29. Abrams DB, Herzog TA, Emmons KM, Linnan L: Stages of change versus addiction: A replication and extension. Nicotine Tob Res 2(3):223-229, 2000.
30. O'Neill HK, Gillispie MA, Slobin K: Stages of change and smoking cessation: A computer-administered intervention program for young adults. Am J Health Prom 15(2):93-96, 2000.
31. Dunbar CR: Application of the transtheoretical model of change to exercise behavior among Type 2 diabetics. Dissertation Abstracts International: Section B: The Sciences & Engineering 61(3-B):1631, 2000.
32. Rodgers WM, Courneya KS, Bayduza AL: Examination of the transtheoretical model and exercise in 3 populations. Am J Health Behav 25(1):33-41, 2001.
33. Harlow LL, Prochaska JO, Redding CA, Rossi JS, Velicer WF, Snow MG, Schnell D, Galavotti C, O'Reilly K, Rhodes F: Stages of condom use in a high HIV-risk sample. Psychol Health 14(1):143-157, 1999.
34. Vernon SW: Participation in colorectal cancer screening; A review. J Nat Cancer Instit 89:1406-1422, 1997.
35. Schoen RE, Weissfeld JL, Kuller LH: Sigmoidoscopy use among primary care physicians. Prev Med 24(3):249-254, 1995.
36. Gordon NP, Rundall TG, Parker L: Type of health care coverage and the likelihood of being screened for cancer. Med Care 36(5):636-645, 1998.
37. Burke W, Beeker C, Kraft JM, Pinsky L: Engaging women's interest in colorectal cancer screening: A public health strategy. J Womens Health Gend Based Med 9(4):363-371, 2000.
38. Friedman LC, Webb JA, Richards CS, Plon SE: Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 29(2):119-125, 1999.